HIV-1 chemotherapy and drug resistance
- 1 May 1995
- journal article
- review article
- Published by Elsevier in Clinical and Diagnostic Virology
- Vol. 3 (4) , 299-316
- https://doi.org/10.1016/0928-0197(94)00064-2
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Zidovudine Resistance and HIV-1 Disease Progression during Antiretroviral TherapyAnnals of Internal Medicine, 1995
- HIV-1 Drug Resistance: Molecular Pathogenesis and Laboratory MonitoringClinics In Laboratory Medicine, 1994
- Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infectionThe Lancet, 1994
- HIV-1 error revealedNature, 1993
- Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolatesAntimicrobial Agents and Chemotherapy, 1993
- Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapyNature, 1993
- HIV-1 sensitivity to zidovudine: A consensus culture technique validated by genotypic analysis of the reverse transcriptaseJournal of Virological Methods, 1992
- Genetic Diversity and Evolution of RetrovirusesPublished by Springer Nature ,1992
- Ordered Appearance of Zidovudine Resistance Mutations during Treatment of 18 Human Immunodeficiency Virus-Positive SubjectsThe Journal of Infectious Diseases, 1992
- Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapyThe Lancet, 1990